NEAM
GSK icon

New England Asset Management’s GSK GSK Stock Holding History

New England Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,074
Closed -$255K – 187
2018
Q3 		$255K Hold
5,074
– – ﹤0.01% 175
2018
Q2 		$256K Buy
+5,074
New +$256K ﹤0.01% 171
2017
Q4 		– Sell
-15,879
Closed -$806K – 156
2017
Q3 		$806K Hold
15,879
– – 0.02% 104
2017
Q2 		$856K Sell
15,879
-2,480
-14% -$132K 0.03% 89
2017
Q1 		$968K Buy
18,359
+8,880
+94% +$450K 0.02% 99
2016
Q4 		$456K Sell
9,479
-8,880
-48% -$439K 0.01% 111
2016
Q3 		$990K Hold
18,359
– – 0.04% 99
2016
Q2 		$994K Buy
18,359
+8,400
+84% +$443K 0.04% 97
2016
Q1 		$505K Hold
9,959
– – 0.02% 107
2015
Q4 		$502K Sell
9,959
-13,840
-58% -$705K 0.01% 109
2015
Q3 		$1.14M Sell
23,799
-4,720
-17% -$246K 0.03% 98
2015
Q2 		$1.49M Sell
28,519
-1,249
-4% -$70.3K 0.04% 95
2015
Q1 		$1.72M Buy
29,768
+3,688
+14% +$211K 0.04% 95
2014
Q4 		$1.39M Sell
26,080
-43,120
-62% -$2.41M 0.03% 96
2014
Q3 		$3.98M Sell
69,200
-2,320
-3% -$142K 0.1% 66
2014
Q2 		$4.78M Buy
71,520
+560
+0.8% +$37.9K 0.11% 65
2014
Q1 		$4.74M Sell
70,960
-80
-0.1% -$5.41K 0.12% 58
2013
Q4 		$4.74M Sell
71,040
-400
-0.6% -$25.9K 0.12% 59
2013
Q3 		$4.48M Buy
71,440
+2,000
+3% +$129K 0.13% 57
2013
Q2 		$4.34M Buy
+69,440
New +$4.41M 0.13% 55

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

New England Asset Management's GSK Position: Q4 2018 in Review

New England Asset Management sold out of GSK (GSK) in Q4 2018, closing a stake of 5,074 shares — an estimated $255K sold.

New England Asset Management first reported a position in GSK in Q2 2013 and held it in 20 quarters. The position peaked at $4.78M in Q2 2014. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • New England Asset Management reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • New England Asset Management sold 5,074 GSK shares in Q4 2018, an estimated $255K.
  • New England Asset Management first reported a position in GSK in Q2 2013 and held it in 20 quarters.
  • New England Asset Management's GSK position peaked at $4.78M in Q2 2014.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on New England Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.